Hyundai Motor America on May 1 announced the expansion of its support for COVID-19 drive-thru testing to 22 hospitals nationwide with more than $4 million in grants through its Hyundai Hope On Wheels program.
The grants are designed to combat the novel coronavirus by providing increased access to testing throughout the nation, Hyundai officials said.
The Fountain Valley-based company also announced an in-kind donation of 65,000 COVID-19 RT-PCR tests developed by Seegene, a South Korea-based global leader in multiplex molecular diagnostics.
Seegene's test can simultaneously detect three different genes of SARS-CoV-2, the virus responsible for COVID-19.
Hyundai is the only automaker providing these testing capabilities to hospitals, especially in hard-hit cities like New Orleans, Chicago and Detroit, officials said.
“As a global automaker, we continue to monitor the COVID-19 situation and its potential harm to the U.S. and beyond,” said Jose Muñoz, president and CEO of Hyundai Motor North America. “A best practice that was crucial in South Korea’s handling of the coronavirus was drive-thru testing. This approach protects the healthcare workers and patients from the potential spread of the virus, while diagnosing those most in need.”
Hyundai and its more than 825 dealers have also provided support to local institutions with financial assistance, food donations, face mask headband production and loaned vehicles.
Additional support has been provided to Hyundai owners and first responders through the company’s Hyundai Assurance program. To learn more about Hyundai Hope On Wheels COVID-19 Drive-Thru Testing Centers and view the most updated list of partnering hospitals, visit www.hyundaihopeonwheels.org.